Chemo

In this video, Brian T. Hill, MD, PhD, discusses research that evaluated the effectiveness of chemo-immunotherapy against three novel combination therapies in the second line or later for patients with relapsed/refractory large B-cell lymphoma.

“Chemo brain” — a collection of cognitive symptoms related to memory, concentration and organization — is a potentially upsetting and debilitating adverse effect of cancer treatment.